A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Vortioxetine Impurity 37 - Request Quote

Picture of Vortioxetine Impurity 37

Vortioxetine Impurity 37

SZ CAT No:SZ-V018046
CAS No
NA
Mol.F.
C40H51N5S2
Mol.Wt.
666.0
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Vortioxetine Impurity 37 is chemically Bis(2-(4-(2-((2,4-dimethylphenyl)thio)phenyl)piperazin-1-yl)ethyl)amine. Vortioxetine Impurity 37 is supplied with detailed characterization data compliant with regulatory guideline. Vortioxetine Impurity 37 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Vortioxetine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Vortioxetine Impurity 37

Purchase Vortioxetine Impurity 37

Vortioxetine Impurity 37 suppliers

Vortioxetine Impurity 37 manufacturers

Vortioxetine Impurity 37 price

Order Vortioxetine Impurity 37

Enquire Vortioxetine Impurity 37

Vortioxetine Impurity 37 cost

Vortioxetine Impurity 37 Supplier

Vortioxetine Impurity 37 Distributor

Vortioxetine Impurity 37 for Method Validation

Vortioxetine Reference Standard

Vortioxetine Impurity 37 for ANDA Filing

Vortioxetine Impurity 37 for Forced Degradation Studies

Vortioxetine Impurity 37 Identification Standards

Vortioxetine Impurity 37 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,